Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:20 PM EDT
158.26quote price arrow up+0.07 (+0.04%)
Volume
1,181,365
Close
158.19quote price arrow up+0.23 (+0.15%)
Volume
4,994,004
52 week range
144.95 - 175.97
Loading...
  • Open158.20
  • Day High159.14
  • Day Low158.11
  • Prev Close157.96
  • 52 Week High175.97
  • 52 Week High Date08/10/23
  • 52 Week Low144.95
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap381.204B
  • Shares Out2.41B
  • 10 Day Average Volume7.66M
  • Dividend4.76
  • Dividend Yield3.01%
  • Beta0.53
  • YTD % Change0.93

KEY STATS

  • Open158.20
  • Day High159.14
  • Day Low158.11
  • Prev Close157.96
  • 52 Week High175.97
  • 52 Week High Date08/10/23
  • 52 Week Low144.95
  • 52 Week Low Date10/27/23
  • Market Cap381.204B
  • Shares Out2.41B
  • 10 Day Average Volume7.66M
  • Dividend4.76
  • Dividend Yield3.01%
  • Beta0.53
  • YTD % Change0.93

RATIOS/PROFITABILITY

  • EPS (TTM)5.32
  • P/E (TTM)29.72
  • Fwd P/E (NTM)14.86
  • EBITDA (TTM)30.987B
  • ROE (TTM)18.31%
  • Revenue (TTM)85.159B
  • Gross Margin (TTM)69.18%
  • Net Margin (TTM)15.65%
  • Debt To Equity (MRQ)42.65%

EVENTS

  • Earnings Date04/16/2024
  • Ex Div Date02/16/2024
  • Div Amount1.19
  • Split Date-
  • Split Factor-

Profile

MORE
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...
Joaquin Duato
Chairman of the Board, Chief Executive Officer
Joseph Wolk
Chief Financial Officer, Executive Vice President
Tim Schmid
Executive Vice President, Worldwide Chairman of MedTech
Elizabeth Forminard
Executive Vice President, General Counsel
John Reed M.D., Ph.D.
Executive Vice President - Pharmaceuticals, R&D
Address
One Johnson & Johnson Plaza
New Brunswick, NJ
08933
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
131.95+0.20+0.15%
ABBV
AbbVie Inc
182.10+1.75+0.97%
RHHBY
Roche Holding AG
31.92+0.61+1.95%
NVS
Novartis AG
96.73+0.85+0.89%
AZN
AstraZeneca PLC
67.75-0.51-0.75%